Abcam Expresses Surprise At Dr. Milner's Actions, Believes His Opposition May Be An Attempt To Create Confusion Among Shareholders Before The Vote
Portfolio Pulse from Benzinga Newsdesk
Abcam plc (NASDAQ:ABCM) has expressed surprise at Dr. Jonathan Milner's opposition to the proposed acquisition of all outstanding shares of Abcam by Danaher Corporation (DHR) for $24.00 per share in cash. The company believes this may be an attempt to create confusion among shareholders before the vote.
September 15, 2023 | 6:07 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Dr. Milner's opposition to the acquisition deal may create uncertainty among Abcam's shareholders, potentially affecting the stock's stability.
Dr. Milner's opposition to the acquisition deal could lead to uncertainty among shareholders, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
The opposition to the acquisition deal by Dr. Milner may create uncertainty around Danaher's planned acquisition, potentially affecting the stock's stability.
The opposition to the acquisition deal by Dr. Milner could lead to uncertainty around Danaher's planned acquisition, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80